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Why Do Some
Primate Malarias
Relapse?
Nicholas J. White1,2,*
Relapse may have evolved in
malaria as a mechanism to avoid
suppression by more virulent spe-
cies in mixed infections, thereby
increasing transmission opportuni-
ties. Later evolution of long latency918 Trends in Parasitology, December 2016, Vol. 32, No. 1in Plasmodium vivax was a neces-
sary adaptation as early hominins
moved to colder areas with shorter
mosquito breeding seasons.
Genetic diversity was maintained
through heterologous hypnozoite
activation.Sleeping Parasites
Sporozoan (apicomplexan) parasites have
developed many different mechanisms to
facilitate persistence in their hosts. Plas-
modial parasites persist through continu-
ous multiplication in blood for extended
periods. In several of the primate malarias
an alternative strategy has evolved. Some
of the sporozoites persist as sleeping
forms or ‘hypnozoites’, which lie dormant
in the liver hepatocytes for long periods
after inoculation and wake weeks or
months after inoculation [1]. These relap-
ses have a remarkable periodicity [2]. In
humans, Plasmodium vivax is the main
cause of relapsing malaria. There are an
estimated 100–400 million cases each
year mainly in Asia, Oceania, the horn of
Africa and South America. P. vivax is much
more difﬁcult than Plasmodium falciparum
to eliminate, largely because of relapses
which are a major contributor to morbidity.
But why do P. vivax, Plasmodium ovale
and some other primate malarias relapse?
What evolutionary pressure led to this
remarkable adaptation? I propose that it
arose in these primate parasites as an
adaptive ‘defensive’ response to concom-
itant symptomatic infections with virulent
parasites such as Plasmodium falciparum
or other now extinct species.
Epidemiology and Early Evolution
Premunition to P. vivax develops more
rapidly than to P. falciparum [3]. This is
largely because of frequent relapse–a sin-
gle inoculation giving rise to multiple epi-
sodes of illness in the case of P. vivax but
only one in the case of P. falciparum.
Before the era of modern medicine, this
difference would presumably have been
smaller, as primary infections of either
species would have persisted in the blood2for weeks or months, unless challenged
by superinfection. In all epidemiological
contexts, relapse is an important contrib-
utor to P. vivax incidence and prevalence.
In tropical regions, relapse intervals are
short and frequent. The ﬁrst relapse para-
sites begin to emerge from the liver
approximately 4 weeks after sporozoite
inoculation (2 weeks after the primary ill-
ness) and reach patency (detectable para-
sitaemias) approximately 1 week later [2].
The infection becomes transmissible just
before this. In temperate regions, where
mosquito breeding seasons are short and
P. vivax is obliged to overwinter in
humans, the intervals to ﬁrst relapse are
much longer [2]. Adaptation to temperate
climes would have occurred later as hom-
inins ventured further north from the tropi-
cal areas long after the evolution of the
relapse mechanism.
If P. vivax emerged as a primate malaria
parasite in the forests of Africa, then it
would always have had to contend with
more virulent, more rapidly developing,
and generally dominant malaria parasites
with which it shared mosquito vectors and
primate hosts. When P. falciparum and P.
vivax are inoculated together, then P. fal-
ciparum usually dominates [4,5]; it devel-
ops more rapidly in the liver and then the
symptomatic blood stage infection sup-
presses asexual multiplication of P. vivax.
Despite this, there is a remarkably high
rate of mixed infections with the two spe-
cies, so both are commonly transmitted
together [6,7]. In higher transmission set-
tings there is cross-species regulation of
parasite densities [7]. Through a range of
different epidemiological circumstances,
the two malaria parasites are effectively
in competition. Under similar conditions
of competition the relapse mechanism
evolved in the predecessors of today's
primate plasmodial parasites.
Intrahost Competition
In contrast with P. falciparum, P. vivax
gametocytogenesis occurs immediately,
so the infection is transmissible as soon
as it reaches densities in blood that are
sufﬁcient for gametocyte ingestion by
feeding anopheline mosquitos. But as
sexual parasites are derived from asexual
parasites, anything that suppresses asex-
ual multiplication reduces overall transmis-
sibility of the infection. Transmissibility is
greatest during higher-density infections
which generate larger numbers of game-
tocytes. Competition with the predeces-
sor of P. falciparum (or other more virulent
parasites, such as the parasite which
drove Duffy negativity to ﬁxation in much
of Africa) in human primate ancestors pro-
vided an evolutionary selection pressure
on other malaria parasites to avoid sup-
pression in the acute phase of mixed
malaria infections.
During the acute phase of the infection,
before the acquisition of disease control-
ling immunity, nonspeciﬁc host defence
mechanisms comprising fever, proinﬂam-
matory cytokine release, and splenic acti-
vation contain the infection in most cases.
As a byproduct this limits the expansion of
any concomitant infection. Although P.
vivax is a more potent inducer of this
host-defence response than P. falcipa-
rum, we know from the simultaneous
inoculation experiments in human volun-
teers and malaria therapy that P. falcipa-
rum usually predominates [4–6]. Thus P.
vivax gets hit in the crossﬁre and retreats.
But once the acute illness has subsided
there is less impediment to P. vivax multi-
plication. In many tropical areas, the ﬁrst
relapse coincides with a decline in
P. falciparum parasitaemia in untreated
infections, as antibodies to the predomi-
nant P. falciparum PfEMP1 variant
expressed at the surface of the red blood
cell rise [8]. P. vivax also has gene families
suggesting antigenic variation, and can
also persist in the blood for protracted
periods in nonimmune individuals,
although how it does so is not well under-
stood. However, it seems likely that per-
sistence of a blood stage infection of P.
vivax at the densities necessary for trans-
mission would result in a signiﬁcant
immune response and, without antigenic
variation, clearance of the infection.Disappearance from the blood without
providing an ‘immunizing dose’ of infec-
tion, under suppression from P. falcipa-
rum (or its evolutionary precursor) and
reappearance weeks or months later is
a much more efﬁcient strategy to generate
transmissible densities of sexual
parasites.
In a mixed infection, the acute illness asso-
ciated with falciparum malaria suppresses
the concomitant blood stages of P. vivax
reducing their densities and thus trans-
missibility. The illness also delays or pre-
vents development of any developing P.
vivax liver stage parasites by reducing the
availability of iron through increases in
hepcidin (the main hormone regulating
iron availability) [9]. As sporozoite inocula
are generally thought to be small (median
six to ten sporozoites), these two factors
reduce the transmission potential of spor-
ozoites that activate immediately after
arrival to the liver. Delaying activation until
the nonspeciﬁc host responses have
attenuated or abated would increase the
probability of generating and maintaining
transmissible parasite densities. This is
‘place betting’. Through this mechanism,
P. vivax can establish and transmit if there
is no coinfection, or retreat and transmit
later if there is. It also increases the prob-
ability that minor populations in mixed
genotype P. vivax infections can transmit.
Even if a heterologous genotype is out-
competed in the primary infection, while it
has hypnozoites in the liver, it still has a
chance to transmit every time it relapses.
With multiple rolls of the dice, the proba-
bility of successful transmission increases.
Relapse therefore makes most efﬁcient
use of the inoculated sporozoites to opti-
mize the probability of transmission.
Evolutionary Advantages of
Relapse
Systemic febrile illness (such as falciparum
or vivax malaria) may activate relapses
[2,10]. This links infections of different spe-
cies and provides a highly effective mech-
anism for ensuring genetic recombination
between unrelated P. vivax parasites inTretimes or places where transmission is
low. Nonspeciﬁc activation by febrile ill-
ness or another stimulus may result in
the simultaneous development of hypno-
zoites from the same (homologous) and
earlier (heterologous) inoculations. In
anopheline vectors feeding during the
ensuing blood stage infection, male and
female gametes derived from the different
inoculations can mate (heterologous
recombination) creating genetic diversity
[2,11]. This maximizes the opportunities
for both transmission (even if there is
homologous strain immunity) and immune
evasion, and it explains how P. vivax main-
tains high genetic diversity even in areas of
very low seasonal transmission. The evo-
lutionary advantage of P. vivax linking to P.
falciparum, whilst avoiding it during the
acute phase, may be to exploit transmis-
sion conditions optimally. A symptomatic
P. falciparum infection is unequivocal evi-
dence of the recent availability of vector
mosquitoes. For a sleeping hypnozoite,
the optimal time to wake is when vector
mosquitos are abundant but the ﬁre of P.
falciparum acute illness has subsided, so
that effective P. vivax multiplication is
unhindered. If the illness associated with
relapse is sufﬁciently severe, this will acti-
vate further hypnozoites creating regular
periodicity (every 3 weeks approximately).
Illness is a sign of inadequate immunity,
and that translates into an increased prob-
ability that the subsequent relapse can
reach patency. When immunity to P. fal-
ciparum is acquired more slowly than to
P. vivax, as in many low-transmission set-
tings, then falciparum malaria in adults
may wake P. vivax hypnozoites that would
not be woken by asymptomatic vivax
malaria.
As early man moved north to areas where
winter temperatures were inhospitable to
mosquitos and fell below those allowing
sporogony, there was less competition
from P. falciparum, but there were also
fewer opportunities for relapse activation
in the short summer transmission season.
Early relapse became a wasted transmis-
sion opportunity, and a clock evolved sonds in Parasitology, December 2016, Vol. 32, No. 12 919
that the relapse came to coincide with
next year's anopheline vector abun-
dance. Notably, second relapses were
at 3-week intervals as in the tropical
strains. Eventually, further north, with
even shorter transmission seasons, the
opportunity to transmit from the primary
illness diminished, and nearly all the inoc-
ulated sporozoites became dormant hyp-
nozoites [2,12]. Long-latency P. vivax had
become long-incubation-period P. vivax
(hibernans).
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